Skip to main content
Top
Published in: Abdominal Radiology 1/2011

01-02-2011

Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population

Authors: Marc Engelbrecht, Oguz Akin, Devesh Dixit, Lawrence Schwartz

Published in: Abdominal Radiology | Issue 1/2011

Login to get access

Abstract

The purpose of this study was to examine the distribution of venous thrombi associated with primary or secondary abdominal malignancies on magnetic resonance (MR) imaging with respect to thrombus type (bland vs. tumor), tumor sites, tumor types, and veins involved in a large oncologic patient population. In a retrospective review of 10,908 oncologic patients, MR imaging studies identified 142 (1.3%) showing venous thrombi, of which 55 (0.5%) were bland and 87 (0.79%) were tumor thrombus. Bland thrombi were most commonly seen in liver (35%; 19/55) and retroperitoneal malignancies (24%; 13/55) and were most often located in the inferior vena cava (45%; 25/55) and the portal vein (22%; 12/55). Tumor thrombi were most commonly seen in renal (55%; 48/87) and liver (32%; 28/87) malignancies. The prevalence of tumor thrombi was 8.8% (48/545) in primary renal, 4.7% (6/126) in primary retroperitoneal, 2.9% (19/634) in primary liver, and 1.8% (9/479) in secondary liver malignancies. Tumor thrombi were most commonly located in the inferior vena cava (57%; 50/87), the renal vein (48%; 42/87), and the portal vein (29%; 25/87).
Literature
1.
go back to reference Kaufman LB, Yeh BM, Breiman RS, et al. (2005) Inferior vena cava filling defects on CT and MRI. AJR Am J Roentgenol 185:717–726CrossRefPubMed Kaufman LB, Yeh BM, Breiman RS, et al. (2005) Inferior vena cava filling defects on CT and MRI. AJR Am J Roentgenol 185:717–726CrossRefPubMed
2.
go back to reference Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 168:719–723PubMed Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 168:719–723PubMed
3.
go back to reference Aslam Sohaib SA, Teh J, Nargund VH, et al. (2002) Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 167:1271–1275CrossRefPubMed Aslam Sohaib SA, Teh J, Nargund VH, et al. (2002) Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 167:1271–1275CrossRefPubMed
4.
go back to reference Ergen FB, Hussain HK, Caoili EM, et al. (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 182:217–225PubMed Ergen FB, Hussain HK, Caoili EM, et al. (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 182:217–225PubMed
5.
go back to reference Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145:20–23PubMed Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145:20–23PubMed
6.
go back to reference Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR (1989) Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg 210:387–392CrossRefPubMed Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR (1989) Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg 210:387–392CrossRefPubMed
7.
go back to reference Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59:390–395CrossRefPubMed Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59:390–395CrossRefPubMed
8.
go back to reference O’Donohoe MK, Flanagan F, Fitzpatrick JM, Smith JM (1987) Surgical approach to inferior vena caval extension of renal carcinoma. Br J Urol 60:492–496CrossRefPubMed O’Donohoe MK, Flanagan F, Fitzpatrick JM, Smith JM (1987) Surgical approach to inferior vena caval extension of renal carcinoma. Br J Urol 60:492–496CrossRefPubMed
9.
go back to reference Tsuji Y, Goto A, Hara I, et al. (2001) Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. J Vasc Surg 33:789–796CrossRefPubMed Tsuji Y, Goto A, Hara I, et al. (2001) Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. J Vasc Surg 33:789–796CrossRefPubMed
10.
go back to reference Johnson CD, Dunnick NR, Cohan RH, Illescas FF (1987) Renal adenocarcinoma: CT staging of 100 tumors. AJR Am J Roentgenol 148:59–63PubMed Johnson CD, Dunnick NR, Cohan RH, Illescas FF (1987) Renal adenocarcinoma: CT staging of 100 tumors. AJR Am J Roentgenol 148:59–63PubMed
11.
go back to reference Horan JJ, Robertson CN, Choyke PL, et al. (1989) The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging. J Urol 142:943–948PubMed Horan JJ, Robertson CN, Choyke PL, et al. (1989) The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging. J Urol 142:943–948PubMed
12.
go back to reference Myneni L, Hricak H, Carroll PR (1991) Magnetic resonance imaging of RCC with extension into the vena cava: staging accuracy and recent advances. Br J Urol 68:571–578CrossRefPubMed Myneni L, Hricak H, Carroll PR (1991) Magnetic resonance imaging of RCC with extension into the vena cava: staging accuracy and recent advances. Br J Urol 68:571–578CrossRefPubMed
13.
go back to reference Kallman DA, King BF, Hattery RR, et al. (1992) Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 16:240–247CrossRefPubMed Kallman DA, King BF, Hattery RR, et al. (1992) Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 16:240–247CrossRefPubMed
14.
go back to reference Roubidoux MA, Dunnick NR, Sostman HD, Leder RA (1992) Renal cell carcinoma: detection of venous extension with gradient-echo MR imaging. Radiology 182:269–272PubMed Roubidoux MA, Dunnick NR, Sostman HD, Leder RA (1992) Renal cell carcinoma: detection of venous extension with gradient-echo MR imaging. Radiology 182:269–272PubMed
15.
go back to reference Welch TJ, LeRoy AJ (1997) Helical and electron beam CT scanning in the evaluation of renal vein involvement in patients with renal cell carcinoma. J Comput Assist Tomogr 21:467–471CrossRefPubMed Welch TJ, LeRoy AJ (1997) Helical and electron beam CT scanning in the evaluation of renal vein involvement in patients with renal cell carcinoma. J Comput Assist Tomogr 21:467–471CrossRefPubMed
16.
go back to reference Laissy JP, Menegazzo D, Debray MP, et al. (2000) Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography. Eur Radiol 10:1138–1143CrossRefPubMed Laissy JP, Menegazzo D, Debray MP, et al. (2000) Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography. Eur Radiol 10:1138–1143CrossRefPubMed
17.
go back to reference Connolly GC, Chen R, Hyrien O, et al. (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res 122:299–306CrossRefPubMed Connolly GC, Chen R, Hyrien O, et al. (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res 122:299–306CrossRefPubMed
18.
go back to reference Jonas S, Bechstein WO, Steinmüller T, et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080–1086CrossRefPubMed Jonas S, Bechstein WO, Steinmüller T, et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080–1086CrossRefPubMed
19.
go back to reference Takizawa D, Kakizaki S, Sohara N, et al. (2007) Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 52:3290–3295CrossRefPubMed Takizawa D, Kakizaki S, Sohara N, et al. (2007) Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 52:3290–3295CrossRefPubMed
20.
go back to reference Minagawa M, Makuuchi M (2006) Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 12:7561–7567PubMed Minagawa M, Makuuchi M (2006) Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 12:7561–7567PubMed
21.
go back to reference Heaston DK, Chuang VP, Wallace S, de Santos LA (1981) Metastatic hepatic neoplasms: angiographic features of portal vein involvement. AJR Am J Roentgenol 136:897–900PubMed Heaston DK, Chuang VP, Wallace S, de Santos LA (1981) Metastatic hepatic neoplasms: angiographic features of portal vein involvement. AJR Am J Roentgenol 136:897–900PubMed
22.
go back to reference Lee KF, Chu W, Lai PB (2005) Portal vein tumor thrombus in colorectal liver metastasis. Am J Surg 190:364–365CrossRefPubMed Lee KF, Chu W, Lai PB (2005) Portal vein tumor thrombus in colorectal liver metastasis. Am J Surg 190:364–365CrossRefPubMed
23.
go back to reference Hoehn W, Hermanek P (1983) Invasion of veins in renal cell carcinoma—frequency, correlation, and prognosis. Eur Urol 9:276–280PubMed Hoehn W, Hermanek P (1983) Invasion of veins in renal cell carcinoma—frequency, correlation, and prognosis. Eur Urol 9:276–280PubMed
24.
go back to reference Nesbitt JC, Soltero ER, Dinney CPN, et al. (1997) Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63:1592–1600CrossRefPubMed Nesbitt JC, Soltero ER, Dinney CPN, et al. (1997) Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63:1592–1600CrossRefPubMed
25.
go back to reference Pagano F, Dal Bianco M, Artibani W, et al. (1992) Renal cell carcinoma with extension into the inferior vena cava: problems in diagnosis, staging, and treatment. Eur Urol 22:200–203PubMed Pagano F, Dal Bianco M, Artibani W, et al. (1992) Renal cell carcinoma with extension into the inferior vena cava: problems in diagnosis, staging, and treatment. Eur Urol 22:200–203PubMed
Metadata
Title
Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population
Authors
Marc Engelbrecht
Oguz Akin
Devesh Dixit
Lawrence Schwartz
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2011
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-010-9608-6

Other articles of this Issue 1/2011

Abdominal Radiology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine